Defects of mutant DNMT1 are linked to a spectrum of neurological disorders
Jonathan Baets(University of Antwerp), Christopher J. Klein(Mayo Clinic), Steven S. Scherer(University of Pennsylvania), Yo-Tsen Liu(National Yang Ming Chiao Tung University), Mary M. Reilly(National Hospital for Neurology and Neurosurgery), Kaori Hojo, Joachim Weis(Universitätsklinikum Aachen), Noah Beadell(Oregon Health & Science University), Inès Mademan(University of Antwerp), Georges Mer(Mayo Clinic), Jessica Deleon(University of California, San Francisco), Murray Grossman(University of Pennsylvania), Matilde Laurá(National Hospital for Neurology and Neurosurgery), Peter Van den Bergh(Cliniques Universitaires Saint-Luc), Jan Senderek(Friedrich Baur Stiftung), Gregory A. Worrell(Mayo Clinic), Julie Khoury(Oregon Health & Science University), William W. Seeley(University of California, San Francisco), Henry Houlden(Queen Mary University of London), Yanhong Wu(Shandong University of Technology), Xiaohui Duan(Peking University), N. M. McGrath(Northland District Health Board), Peter De Jonghe(University of Antwerp), Shana L. Merrill(University of Pennsylvania), P. James B. Dyck(Mayo Clinic), Gordon Smith(University of Utah), Maria Victoria Botuyan(Mayo Clinic)
Cited by 122
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
Cost of disorders of the brain in Europe 2010
|European Neuropsychopharmacology|2011|1.7k
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A
|Nature Genetics|2004|1.6k